查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1858256

動脈動脈粥狀硬化斑塊切除術器械市場：2025-2032年全球預測（按器械類型、應用、最終用戶和方式分類）

Atherectomy Devices Market by Device Type, Application, End-User, Mode Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，動脈粥狀硬化斑塊切除術設備市場將成長至 20.2 億美元，複合年成長率為 8.69%。

關鍵市場統計數據
基準年 2024 10.3億美元
預計年份：2025年 11.2億美元
預測年份 2032 20.2億美元
複合年成長率 (%) 8.69%

全面介紹器材創新、臨床實務變革與診療路徑需求如何重塑介入醫師的動脈粥狀斑塊切除動脈粥狀硬化斑塊切除術格局。

動脈粥狀硬化斑塊切除術裝置在現代周邊和冠狀動脈介入治療中發揮著至關重要的作用，能夠有效治療傳統球囊血管成形術和支架置放術難以根治的鈣化和複雜動脈粥狀硬化病變。臨床上對精準斑塊修整的需求，以及對提高手術效率和最大限度減少後續併發症的追求，推動了斑塊切除裝置的不斷發展。創新技術涵蓋機械式、定向式、軌道式和雷射系統，每種系統都旨在應對不同的病變形態和解剖結構挑戰，同時適應臨床醫生的偏好和醫療機構的工作流程。

除了器械機制之外，相關人員的期望如今還擴展到能夠縮短手術時間、降低栓塞風險並促進當日出院的綜合解決方案。醫療保險報銷環境、手術指南以及對門診介入治療日益成長的需求正在重塑這些器械的應用地點和方式。隨著臨床團隊追求最佳患者療效，他們在選擇動脈粥狀硬化斑塊切除術方案時，越來越重視手術的相對安全性、易用性、培訓要求以及對術後護理的影響。

隨著新一代治療模式（例如連續和間歇性治療）的引入，以及栓塞保護和血管內成像等輔助技術的日益複雜，決策矩陣正變得愈發多樣化。因此，器械製造商、臨床領導者和醫療系統採購人員必須應對一個複雜的局面：臨床療效、營運適應性和監管合規性共同決定影響手術路徑和患者照護軌蹟的策略選擇。

臨床影像、門診護理趨勢和器械機械差異化如何推動動脈粥狀硬化斑塊切除術手術策略和應用過程的根本性變革

動脈粥狀硬化斑塊切除術領域的變革性變化反映了臨床、技術和醫療服務趨勢的交匯融合，這些趨勢正在重新定義手術模式。隨著血管內影像和生理評估工具指南器械選擇，臨床醫生正在採用更精準的病變準備策略，從而推動個人化治療方案的實施，使器械的力學特性與斑塊成分相匹配。這導致定向、雷射、軌道和旋轉系統等器械之間的差異化程度不斷提高，每種器械都根據病變的複雜性和解剖因素，開闢了特定的臨床應用領域。

同時，醫療服務模式正向門診和流動醫療機構轉變，這使得使用者人體工學、縮短手術時間以及與當日出院通訊協定的兼容性成為器械研發的優先事項。器械運作模式（例如連續模式和間歇模式）之間的相互作用會影響熱量輸出、碎片處理和操作技術，迫使製造商創新安全功能和輔助栓塞保護策略。此外，血管外科醫生、介入性心臟病專家和放射科醫生之間的跨學科合作正在加速利用互補器械平台的混合手術方法的發展。

在商業方面，隨著各公司專注於服務交付、培訓項目和降低用戶接受門檻的捆綁式解決方案，競爭日趨激烈。監管審查的加強和報銷機制的不斷演變也促使各公司加強投入，以提案並產生真實世界數據。這些變化共同推動動脈動脈粥狀硬化斑塊切除術的應用範圍從小眾介入擴展到更廣泛的、主導通訊協定為導向的治療路徑，從而優先考慮可預測的治療結果和手術效率。

2025年美國關稅變化對營運和採購的影響：重塑醫療器材相關人員的採購、製造和臨床應用路徑

美國關稅調整將於2025年生效，對醫療設備供應鏈的各個環節都提出了具體的營運要求，影響到動脈粥狀硬化斑塊切除術系統的關鍵組件、資本財進口以及周邊耗材。這些關稅調整迫使製造商重新評估籌資策略，優先考慮區域供應的連續性，並加快與委託製造製造商的磋商，以保障生產計劃。對於那些依賴美國境外專業組件或組裝流程的公司而言，這種調整尤其顯著，促使它們將生產外包到美國附近地區，並實現供應商組合多元化。

為此，醫院、門診手術中心和專科診所的採購部門在選擇醫療器材平台時，更加重視庫存管理、合約條款和整體擁有成本。醫療設備製造商則透過材料清單清單審查、在臨床可行的情況下簡化設計以及選擇性地在地採購採購高價值組件來最佳化成本。此外，製造商也加強與醫療系統的對話，探索寄售模式、庫存管理方案和批量採購協議，以減輕關稅造成的價格波動。

這項政策轉變也促使企業重新關注生命週期支援和服務型收入來源，力求在提供可預測採購方案的同時維持利潤率。重點，臨床醫生和供應鏈領導者正攜手合作，確保在應對關稅環境變化帶來的營運調整時，臨床療效和病人安全始終是重中之重。這促成了醫療設備和耗材領域切實可行的權衡取捨和分階段實施策略。

關鍵細分市場分析揭示了醫療設備機制、臨床適應症、護理環境和操作模式如何共同影響臨床應用和商業性定位。

細分市場分析揭示了不同設備類型、臨床應用、終端用戶環境和操作模式所帶來的細微動態，從而為臨床策略和商業性策略的發展提供了基礎。不同類型的設備——定向定向通常用於偏心病灶中斑塊的精確修整；雷射系統在某些纖維鈣化病灶中具有獨特的優勢；軌道式平台能夠以差異化的切割方式進行環週斑塊打磨；而旋轉式系統則因其熟悉度和在特定病灶群體中久經考驗的性能而被廣泛選擇。這些機械差異會影響訓練需求、手術方案規劃和輔助設備的選擇。

適應症細分突顯了冠狀動脈通路和周邊通路之間的明顯差異。冠狀動脈介入治療通常優先考慮小口徑、高流量血管的管腔重建，而周邊血管手術則需要具備處理較大血管和各種病變形態的靈活性。在周邊通路中，頸動脈介入治療和下肢動脈介入治療的特殊考量指導臨床決策。在下肢策略中，解剖結構活動度、血管大小和動態應力因素進一步區分了膕動脈和股淺動脈介入治療。最終使用者細分突顯了醫療環境對器械選擇和物流流程的影響。門診手術中心強調手術量和當日出院資格，醫院優先考慮器械適用範圍和備用資源，而專科診所則專注於以血管為中心的流程。在專科診所中，門診血管中心和血管實驗室面臨不同的人員配置和影像基礎設施的考量，這些因素會影響器械的應用。

連續運轉和間歇運轉模式的差異會影響操作技術和安全性。連續系統可提供穩定的性能，適用於特定的斑塊形態，而間歇系統可能具有溫度控管優勢或不同的碎屑特性。全面考慮這些區別將有助於制定市場推廣策略、臨床培訓計劃和價值提案，以滿足不同臨床和地理環境下操作者和機構的獨特需求。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢將影響臨床路徑、監管方法和商業性合作策略。

區域趨勢對動脈粥狀硬化斑塊切除術器械的臨床實踐模式、監管方法和商業策略有著顯著影響，美洲、歐洲、中東和非洲以及亞太地區呈現出不同的特徵。在美洲，先進的血管內介入治療計畫和成熟的介入醫師網路正在塑造臨床路徑，促使三級醫療中心的手術量大幅成長，並擴大了門診的手術能力。該地區的報銷機制和供應鏈因素影響採購速度，有利於那些能夠提供完善培訓和全生命週期支援的合作夥伴。

歐洲、中東和非洲地區（EMEA）法規環境和醫療服務模式的多樣性要求企業採取適應性強的市場策略。西歐醫療機構往往優先考慮實證實踐、血管內影像技術的整合以及多學科的手術方案規劃，而該地區的其他市場則可能更注重成本效益高的解決方案和擴充性的培訓計畫。監管時間表和當地採購慣例是決定打入市場策略和產品定位的關鍵因素。

在亞太地區，不斷擴大的心血管醫療基礎設施、微創技術的快速普及以及公私醫療服務相結合的模式，正在創造多元化的機會。在多個市場，周邊動脈疾病手術量的成長以及導管室投資的增加，催生了對功能多樣的醫療器材產品組合的需求。在所有地區，製造商和臨床領導者都必須調整全球產品平台，使其適應當地的臨床工作流程、監管要求和報銷實際情況，並採用差異化的合作模式，使培訓、服務和商業性支援與區域優先事項保持一致。

製造商如何透過臨床培訓、服務模式和整合平台策略來競爭，從而影響手術流程的採用和長期客戶關係？

醫療設備製造商之間的競爭不再局限於器材本身，而是涵蓋了培訓、實證醫學證據、上市後監測以及綜合服務等領域。主要企業正加大對臨床教育計畫、介入團隊實踐培訓以及支持患者選擇和手術方案規劃的數位化工具的投入。這些措施有助於降低器械應用門檻，並增強不同器械類型轉換過程中醫護人員的手術信心。策略夥伴關係和分銷模式也在不斷發展，製造商與醫療系統、培訓中心和影像設備供應商合作，建構涵蓋從方案規劃到術後追蹤整個手術流程的綜合解決方案。

產品研發投資的重點在於提昇平台的多功能性、增強輔助安全功能（例如與栓塞保護裝置的兼容性）以及改進微創入路技術。各公司也透過真實世界數據舉措和註冊登記參與來加強臨床證據，並支持與支付方就療效和資源利用情況展開的討論。庫存管理、現場技術支援和以療效為導向的培訓等差異化服務是關鍵的競爭優勢，尤其是在手術量和成本可預測性會影響採購決策的環境下。

隨著臨床需求和營運限制相互交織，能夠將產品設計、臨床醫生培訓和售後支援與機構工作流程相契合的市場參與者，將更有利於影響長期採購決策。那些優先考慮血管內成像和周邊設備互通性、能夠證明臨床結果可重複性並提供可擴展教育項目的公司，將更有利於在複雜的客戶環境中保持永續的競爭優勢。

針對醫療設備製造商和臨床領導者的實用建議：將培訓、供應鏈韌性和實證實踐與社區醫療保健優先事項相結合

產業領導者應採取多管齊下的方法，將器材創新與臨床教育、在地化適應性和穩健的供應鏈結合。首先，他們應優先投資於全面的臨床醫生培訓項目，這些項目應結合模擬、指導和案例式學習，以加速定向、雷射、軌道和旋轉平台整體器械的安全應用。將血管內影像訓練與器械教育結合，將使臨床醫生能夠最佳化患者選擇和手術流程，減少手術結果的差異，並為特定器械的治療方案提供更有力的臨床證據。

第二，我們將透過多元化零件採購管道、探索關鍵組件的近岸外包以及與醫療系統合作夥伴協商靈活的採購條款，來增強供應鏈的韌性。這些措施將減輕貿易政策變化帶來的營運不確定性，並支持可預測的醫療器材供應。第三，我們將根據區域監管和報銷環境調整策略，並提供靈活的商業模式，例如庫存管理、試點按績效付費合約以及社區服務點，以滿足門診手術中心、醫院和專科診所（包括門診血管中心和血管實驗室）的獨特需求。

第四，我們將加快對真實世界證據項目和註冊登記的投資，以收集冠狀動脈和周邊血管領域的介入治療結果，重點關注特定病變部位，特別是涉及頸動脈、膕動脈和股淺動脈的下肢血管介入治療。最後，我們將制定產品藍圖，在效能提升和易用性之間取得平衡，強調連續和間歇模式下的安全特性，以滿足不同操作者的偏好。這種綜合方法將使製造商和臨床領導者能夠將創新轉化為永續的應用，並改善患者照護路徑。

結合臨床醫師訪談、二手文獻綜述和迭代式同儕檢驗的綜合調查方法，確保了研究結果具有豐富的背景資訊和實際應用價值。

本分析的調查方法融合了第一手資料和第二手資料、定性專家訪談以及迭代檢驗，以確保獲得穩健且富含背景資訊的洞見。第一手資料包括與介入性心臟病專家、血管外科醫生、導管室主任、採購人員和門診手術中心管理人員進行結構化訪談和討論，以收集關於器械性能、手術流程和實施障礙的第一手資訊。除了這些以臨床醫生為中心的對話外，還採訪了監管和報銷方面的專家，以揭示影響器械應用的政策因素和採購趨勢。

這項二次研究對同行評審文獻、臨床指南、手術登記資料和產品技術規格進行了系統性回顧，旨在闡明該器械在冠狀動脈和周邊血管領域的作用機制、安全性以及臨床應用案例。分析還考慮了器械適應症、監管核准情況和已發表的臨床結果數據，以便更好地理解臨床發現。研究採用定性綜合方法，旨在調和醫療專業人員之間有時存在的衝突觀點，並提煉出關於培訓需求、輔助技術以及器械在臨床實踐中的適用性的通用主題。

最後，研究結果檢驗。這種三角驗證的調查方法確保了結論能夠反映當前臨床實際情況、營運限制以及包括門診手術中心、醫院和專科診所（如門診血管中心和血管實驗室）在內的相關人員的戰略重點。

綜合分析臨床需求、營運實際情況和策略性商業性合作將如何推動動脈粥狀硬化斑塊切除術的下一階段應用，並得出相關結論。

對器械機制、臨床路徑、區域趨勢和商業策略的累積分析表明，動脈粥狀硬化斑塊切除術器械正從小眾工具轉變為主導通訊協定血管治療方案為導向的關鍵組成部分。臨床團隊將繼續尋求能夠針對不同病變類型提供可預測性能、與影像和栓塞保護策略無縫銜接，並提供培訓資源以減少治療結果差異的平台。在營運方面，隨著某些手術轉向門診和當日出院模式，支持手術量、安全性和當日出院流程的器械將日益受到重視。

在商業方面，能夠將產品創新與強大的售後支援、靈活的採購模式以及有針對性的證據生成相結合的製造商，將更有利於影響醫療器材的長期選擇。近期政策變更導致的供應鏈調整凸顯了採購彈性和服務型交付模式對於維持醫療連續性的重要性。展望未來，臨床領導者、醫療設備製造商和醫療系統之間的合作將塑造動脈粥狀硬化斑塊切除術應用和標準化的下一階段，重點是治療效果、成本效益和臨床醫生的熟練程度。

在這個不斷變化的環境中取得成功，取決於將臨床療效、營運適應性和策略商業性參與相結合，從而在應對現代醫療保健服務的實際限制的同時，實現患者照護的可衡量改進。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 在周邊動脈疾病的治療中，結合動脈粥狀硬化斑塊切除術和藥物釋放型球囊療法的聯合器械的應用日益增多。
  • 對具備整合成像功能以進行複雜病變導航的定向動脈粥狀硬化斑塊切除術系統的需求日益成長
  • 開發具有自動斑塊減少功能和更高安全性的新一代軌道動脈粥狀硬化斑塊切除術裝置
  • 人們對微創導管動脈動脈粥狀硬化斑塊切除術治療膝下慢性完全閉塞的興趣日益濃厚
  • 新型雷射輔助斑塊修飾技術拓展了冠狀動脈介入治療中動脈粥狀硬化斑塊切除術的適應症。
  • 新興的混合式動脈粥狀硬化斑塊切除術平台結合了雷射和機械方式，用於治療鈣化病變

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依器械類型動脈粥狀硬化斑塊切除術的動脈粥狀硬化切除器械市場

  • 定向
  • 雷射
  • 軌道
  • 旋轉

第9章 依應用分類的動脈動脈粥狀硬化斑塊切除術市場

  • 冠狀動脈
  • 外圍
    • 頸動脈
    • 下肢
      • 膕動脈
      • 股淺動脈

第10章 依最終用戶分類的動脈動脈粥狀硬化斑塊切除術器械市場

  • 門診手術中心
  • 醫院
  • 專科診所
    • 門診血管中心
    • 血管檢查室

第11章 依模式類型分類的動脈動脈粥狀硬化斑塊切除術器械市場

  • 常用表達
  • 間歇性

第12章 按地區分類的動脈動脈粥狀硬化斑塊切除術器械市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 依組別分類的動脈動脈粥狀硬化斑塊切除術器械市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國動脈動脈粥狀硬化斑塊切除術器材市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Boston Scientific Corporation
    • Abbott Laboratories
    • Medtronic plc
    • Koninklijke Philips NV
    • Cardiovascular Systems, Inc.
    • AngioDynamics, Inc.
    • Terumo Corporation
    • Becton, Dickinson and Company
    • OrbusNeich Medical Company Limited
    • ConMed Corporation
Product Code: MRR-8E22B61932A8

The Atherectomy Devices Market is projected to grow by USD 2.02 billion at a CAGR of 8.69% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.03 billion
Estimated Year [2025] USD 1.12 billion
Forecast Year [2032] USD 2.02 billion
CAGR (%) 8.69%

Comprehensive introduction to how device innovation, clinical practice shifts, and care pathway demands are reshaping the atherectomy landscape for interventional specialists

Atherectomy devices occupy a pivotal role in contemporary peripheral and coronary interventional practice, addressing calcified and complex atherosclerotic lesions where conventional balloon angioplasty and stenting may be insufficient. The clinical imperative for precision plaque modification, coupled with procedural efficiency and the desire to minimize downstream complications, has driven continuous device evolution. Innovations span mechanical, directional, orbital, and laser-based systems, each engineered to meet distinct lesion morphology and anatomic challenges while aligning with operator preferences and institutional workflows.

Beyond device mechanics, stakeholder expectations now encompass integrated solutions that reduce procedure time, mitigates embolic risk, and facilitate same-day discharge pathways. Reimbursement environments, procedural guidelines, and growing demand for ambulatory-based interventions are reshaping where and how these devices are deployed. As clinical teams pursue optimal patient outcomes, they increasingly weigh comparative procedural safety, ease of use, training needs, and post-procedural care implications when selecting atherectomy approaches.

The introduction of next-generation mode strategies, including continuous and intermittent operation types, and the refinement of adjunctive technologies such as embolic protection and intravascular imaging, further diversify the decision matrix. Consequently, device manufacturers, clinical leaders, and health system purchasers must navigate a nuanced landscape where clinical efficacy, operational adaptability, and regulatory alignment determine the strategic choices that influence procedural pathways and patient care trajectories.

How clinical imaging, outpatient care trends, and device mechanism differentiation are driving a fundamental shift in atherectomy procedural strategies and adoption dynamics

Transformative shifts in the atherectomy domain reflect a confluence of clinical, technological, and care-delivery trends that are redefining procedural paradigms. Clinicians are adopting more precise lesion-preparation strategies as intravascular imaging and physiologic assessment tools inform device selection, thereby promoting tailored approaches that match device mechanism to plaque composition. This has elevated the importance of device differentiation across directional, laser, orbital, and rotational systems, with each class carving specific clinical niches based on lesion complexity and anatomical considerations.

Simultaneously, care-delivery models are moving toward outpatient and ambulatory settings, prompting device development to prioritize user ergonomics, reduced procedure duration, and compatibility with same-day discharge protocols. The interplay between device mode types-continuous versus intermittent-affects heat generation, debris management, and operator technique, prompting manufacturers to innovate around safety features and adjunctive embolic-protection strategies. Furthermore, cross-disciplinary collaboration between vascular surgeons, interventional cardiologists, and radiologists is accelerating hybrid procedural approaches that leverage complementary device platforms.

On the commercial front, competitive dynamics are intensifying as companies emphasize service offerings, training programs, and bundled solutions to lower adoption barriers. Regulatory scrutiny and evolving reimbursement frameworks have also prompted companies to demonstrate clear clinical value propositions and to invest in real-world evidence generation. Collectively, these shifts are expanding the operational role of atherectomy devices beyond niche interventions into broader, protocol-driven care pathways that prioritize predictable outcomes and procedural efficiency.

Operational and procurement implications of the United States tariff changes in 2025 that are reshaping sourcing, manufacturing, and clinical adoption pathways for device stakeholders

United States tariff changes enacted in 2025 have imposed tangible operational considerations across medical device supply chains, affecting components, capital equipment imports, and peripheral consumables integral to atherectomy systems. The tariff adjustments have prompted manufacturers to re-evaluate sourcing strategies, prioritize regional supply continuity, and accelerate discussions with contract manufacturers to insulate production timelines. This recalibration has been most pronounced for companies that rely on specialized components or assembly operations located outside the United States, prompting nearshoring and diversification of supplier portfolios.

In response, procurement teams at hospitals, ambulatory surgical centers, and specialty clinics have increased focus on inventory management, contract terms, and total cost of ownership when selecting device platforms. Device makers have pursued cost optimization through recalibrated bills of materials, design simplification where clinically feasible, and selective localization of high-value components. These measures have been complemented by intensified dialogues between manufacturers and health systems to explore consignment models, managed inventory programs, and bundled purchasing arrangements that mitigate tariff-driven price volatility.

The policy shift has also stimulated renewed emphasis on lifecycle support and service-based revenue streams, as companies seek to sustain margins while offering predictable procurement options. Importantly, clinicians and supply chain leaders are working together to ensure that clinical efficacy and patient safety remain paramount while navigating operational adjustments prompted by the tariff landscape, leading to pragmatic trade-offs and phased implementation strategies for devices and consumables.

Key segmentation insights revealing how device mechanism, clinical indication, care setting, and operational mode collectively shape clinical adoption and commercial positioning

Segmentation insights reveal nuanced adoption dynamics across device types, clinical applications, end-user settings, and mode types that inform both clinical strategy and commercial focus. Device-type distinctions between directional, laser, orbital, and rotational systems reflect divergent operational profiles: directional systems are often favored for precise plaque modification in eccentric lesions, laser systems provide unique advantages in certain fibro-calcific anatomies, orbital platforms enable circumferential plaque sanding with differential cutting action, and rotational systems are commonly chosen for their familiarity and established performance in select lesion sets. These mechanistic differences shape training requirements, procedure planning, and adjunctive device selection.

Application segmentation underscores distinct coronary and peripheral pathways. Coronary interventions typically prioritize lumen restoration in small-caliber, high-flow vessels, whereas peripheral procedures demand versatility across larger vessels and varied lesion morphologies. Within the peripheral pathway, specific attention to carotid interventions and lower limb arteries directs clinical decision-making; lower limb strategies further differentiate between popliteal artery and superficial femoral artery interventions due to anatomic mobility, vessel size, and biomechanical stressors. End-user segmentation highlights the influence of care setting on device choice and procedural logistics. Ambulatory surgical centers emphasize throughput and same-day discharge compatibility, hospitals prioritize range of device capabilities and backup resources, and specialty clinics focus on vascular-centric workflows; within specialty clinics, outpatient vascular centers and vascular labs each face different staffing and imaging infrastructure considerations that influence device deployment.

Mode type segmentation between continuous and intermittent operation influences procedural technique and safety profiles. Continuous systems can offer steady-state performance suitable for specific plaque morphologies, while intermittent systems may provide thermal management advantages and different debris characteristics. Collectively, these segmentation layers inform go-to-market strategies, clinical training programs, and the development of value propositions tailored to the unique demands of operators and institutions across clinical and geographic contexts.

Regional dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine clinical pathways, regulatory approaches, and commercial engagement strategies

Regional dynamics exert a powerful influence on clinical practice patterns, regulatory approaches, and commercial strategies for atherectomy devices, with distinct characteristics observable across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, clinical pathways are shaped by advanced endovascular programs and established networks of interventional specialists, leading to high procedural volumes in tertiary hospitals and growing throughput in ambulatory settings. Reimbursement frameworks and supply chain considerations within this region influence procurement cadence and favor partners that can provide robust training and lifecycle support.

The Europe, Middle East & Africa region displays heterogeneous regulatory environments and healthcare delivery models, which necessitate adaptable market approaches. Western European centers typically emphasize evidence-based adoption, integration with intravascular imaging, and multidisciplinary procedural planning, while other markets within the broader region may prioritize cost-effective solutions and scalable training programs. Regulatory timelines and national procurement practices are critical variables that shape entry strategies and product positioning.

Asia-Pacific presents diverse opportunities driven by expanding cardiovascular care infrastructure, rapid adoption of minimally invasive techniques, and a mix of public and private healthcare delivery. In several markets, increasing procedure volumes for peripheral arterial disease and investments in catheterization facilities are creating demand for versatile device portfolios. Across all regions, manufacturers and clinical leaders must reconcile global product platforms with local clinical workflows, regulatory requirements, and reimbursement realities, employing differentiated engagement models that align training, service, and commercial support with regional priorities.

How manufacturers are competing through clinical training, service models, and integrated platform strategies to influence procedural adoption and long-term customer relationships

Competitive dynamics among device manufacturers now hinge on more than device mechanics; they encompass training, evidence generation, post-market surveillance, and integrated service offerings. Leading companies are investing in clinical education programs, hands-on training for interventional teams, and digital tools that support patient selection and procedural planning. These capabilities help lower barriers to adoption and increase procedural confidence among operators transitioning between device classes. Strategic partnerships and distribution models are also evolving, with manufacturers collaborating with health systems, training centers, and imaging vendors to create bundled solutions that address entire procedural pathways from planning through follow-up.

Product development investments are channeling into platform versatility, adjunctive safety features such as embolic-protection compatibility, and minimally invasive access enhancements. Companies are also leveraging real-world evidence initiatives and registry participation to strengthen clinical narratives and to support payer discussions centered on outcomes and resource utilization. Service differentiation through managed inventory, on-site technical support, and outcome-focused training has become a key competitive lever, especially in settings where procedural throughput and cost predictability influence purchasing decisions.

Given the intersection of clinical requirements and operational constraints, market players that align product design, clinician training, and post-sales support with institutional workflows are best positioned to influence long-term procurement decisions. Those that emphasize interoperability with intravascular imaging and ancillary devices, demonstrate reproducible clinical outcomes, and deliver scalable education programs will maintain a durable advantage in complex account environments.

Actionable recommendations for device makers and clinical leaders to align training, supply-chain resilience, and evidence generation with regional care delivery priorities

Industry leaders should adopt a multi-pronged approach that aligns device innovation with clinical education, regional adaptability, and resilient supply chains. First, prioritize investments in comprehensive clinician training programs that combine simulation, proctorship, and case-based learning to accelerate safe adoption across directional, laser, orbital, and rotational platforms. Embedding intravascular imaging training alongside device education will help clinicians optimize patient selection and procedural techniques, reducing variability in outcomes and building stronger clinical evidence for device-specific approaches.

Second, bolster supply-chain resilience by diversifying component sourcing, considering nearshoring of critical assemblies, and negotiating flexible procurement terms with health-system partners. These actions will mitigate the operational uncertainties introduced by trade-policy shifts and support predictable device availability. Third, tailor regional strategies to local regulatory and reimbursement landscapes by offering adaptable commercial models such as managed inventory, outcome-based contracting pilots, and localized service hubs that address the unique needs of ambulatory surgical centers, hospitals, and specialty clinics, including outpatient vascular centers and vascular labs.

Fourth, invest in real-world evidence programs and registries that capture procedural outcomes across coronary and peripheral indications, with attention to lesion subsets such as carotid and lower limb interventions involving the popliteal artery and superficial femoral artery. Finally, design product roadmaps that balance performance improvements with simplicity of use, emphasizing safety features for continuous and intermittent mode types to meet diverse operator preferences. This integrated approach will help manufacturers and clinical leaders translate innovation into sustainable adoption and improved patient care pathways.

Integrated research methodology combining clinician interviews, secondary literature review, and iterative expert validation to ensure context-rich and actionable insights

The research methodology underpinning this analysis integrates a blended approach of primary and secondary investigation, qualitative expert engagement, and iterative validation to ensure robust, context-rich insights. Primary inputs included structured interviews and consultations with interventional cardiologists, vascular surgeons, cath lab directors, procurement leaders, and ambulatory surgical center managers to capture firsthand perspectives on device performance, procedural workflow, and adoption barriers. These clinician-centered dialogues were complemented by interviews with regulatory and reimbursement specialists to illuminate policy drivers and procurement dynamics that influence device deployment.

Secondary research encompassed a systematic review of peer-reviewed literature, clinical guidelines, procedure registries, and product technical specifications to map device mechanisms, safety profiles, and clinical use cases across coronary and peripheral applications. The analysis also considered device labeling, regulatory clearances, and published outcomes data to contextualize clinical narratives. Qualitative synthesis methods were applied to reconcile sometimes divergent practitioner perspectives and to surface common themes related to training needs, adjunctive technologies, and care-setting suitability.

Finally, findings were iteratively validated through expert panel reviews and cross-checked against publicly available clinical evidence and procedural best-practice guidance. This triangulated methodology ensured that conclusions reflect current clinical realities, operational constraints, and the strategic priorities of stakeholders across ambulatory surgical centers, hospitals, and specialty clinics including outpatient vascular centers and vascular labs.

Synthesis and concluding perspectives on how clinical demand, operational realities, and strategic commercial engagement will drive the next phase of atherectomy adoption

The cumulative analysis of device mechanisms, clinical pathways, regional dynamics, and commercial strategies indicates that atherectomy devices are transitioning from niche tools to strategic components of protocol-driven vascular care. Clinical teams will continue to demand platforms that offer predictable performance across diverse lesion types, seamless integration with imaging and embolic-protection strategies, and training resources that reduce variability in outcomes. Operationally, the migration of selected procedures to ambulatory and outpatient environments will place a premium on devices that support throughput, safety, and same-day discharge workflows.

Commercially, manufacturers that combine product innovation with robust post-sales support, flexible procurement models, and targeted evidence generation will be better positioned to influence long-term device selection. Supply-chain adjustments prompted by recent policy changes highlight the importance of sourcing flexibility and service-based offerings that maintain continuity of care. Looking ahead, collaborative initiatives between clinical leaders, device makers, and health systems that emphasize outcomes, cost efficiency, and clinician proficiency will shape the next phase of atherectomy adoption and standardization.

Ultimately, success in this evolving landscape will depend on the alignment of clinical efficacy, operational adaptability, and strategic commercial engagement to deliver measurable improvements in patient care while accommodating the practical constraints of contemporary healthcare delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of combination devices integrating atherectomy with drug-coated balloon therapy in peripheral arterial disease management
  • 5.2. Rising demand for directional atherectomy systems with integrated imaging for complex lesion navigation
  • 5.3. Development of next-generation orbital atherectomy devices with automated plaque debulking and enhanced safety features
  • 5.4. Growing focus on minimally invasive catheter-based atherectomy for below-the-knee chronic total occlusions
  • 5.5. Expansion of atherectomy use in coronary interventions driven by novel laser-assisted plaque modification techniques
  • 5.6. Emergence of hybrid atherectomy platforms combining laser and mechanical modalities for calcified lesion treatment

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Atherectomy Devices Market, by Device Type

  • 8.1. Directional
  • 8.2. Laser
  • 8.3. Orbital
  • 8.4. Rotational

9. Atherectomy Devices Market, by Application

  • 9.1. Coronary
  • 9.2. Peripheral
    • 9.2.1. Carotid
    • 9.2.2. Lower Limb
      • 9.2.2.1. Popliteal Artery
      • 9.2.2.2. Superficial Femoral Artery

10. Atherectomy Devices Market, by End-User

  • 10.1. Ambulatory Surgical Center
  • 10.2. Hospitals
  • 10.3. Specialty Clinic
    • 10.3.1. Outpatient Vascular Center
    • 10.3.2. Vascular Lab

11. Atherectomy Devices Market, by Mode Type

  • 11.1. Continuous
  • 11.2. Intermittent

12. Atherectomy Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Atherectomy Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Atherectomy Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Boston Scientific Corporation
    • 15.3.2. Abbott Laboratories
    • 15.3.3. Medtronic plc
    • 15.3.4. Koninklijke Philips N.V.
    • 15.3.5. Cardiovascular Systems, Inc.
    • 15.3.6. AngioDynamics, Inc.
    • 15.3.7. Terumo Corporation
    • 15.3.8. Becton, Dickinson and Company
    • 15.3.9. OrbusNeich Medical Company Limited
    • 15.3.10. ConMed Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. ATHERECTOMY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. ATHERECTOMY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ATHERECTOMY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY DIRECTIONAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY DIRECTIONAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY DIRECTIONAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY DIRECTIONAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY DIRECTIONAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY DIRECTIONAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LASER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LASER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LASER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LASER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LASER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LASER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ORBITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ORBITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ORBITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ORBITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ORBITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ORBITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ROTATIONAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ROTATIONAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ROTATIONAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ROTATIONAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ROTATIONAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ROTATIONAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CORONARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CORONARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CORONARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CORONARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CORONARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CORONARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CAROTID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CAROTID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CAROTID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CAROTID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CAROTID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CAROTID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY POPLITEAL ARTERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY POPLITEAL ARTERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY POPLITEAL ARTERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY POPLITEAL ARTERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY POPLITEAL ARTERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY POPLITEAL ARTERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SUPERFICIAL FEMORAL ARTERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SUPERFICIAL FEMORAL ARTERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SUPERFICIAL FEMORAL ARTERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SUPERFICIAL FEMORAL ARTERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SUPERFICIAL FEMORAL ARTERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SUPERFICIAL FEMORAL ARTERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY OUTPATIENT VASCULAR CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY OUTPATIENT VASCULAR CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY OUTPATIENT VASCULAR CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY OUTPATIENT VASCULAR CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY OUTPATIENT VASCULAR CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY OUTPATIENT VASCULAR CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY VASCULAR LAB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY VASCULAR LAB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY VASCULAR LAB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY VASCULAR LAB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY VASCULAR LAB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY VASCULAR LAB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CONTINUOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CONTINUOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CONTINUOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CONTINUOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CONTINUOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CONTINUOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY INTERMITTENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY INTERMITTENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY INTERMITTENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY INTERMITTENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY INTERMITTENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY INTERMITTENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 125. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 129. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 131. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 144. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 146. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 150. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 160. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 164. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 166. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 208. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 212. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 214. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 225. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 226. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 227. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 228. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 229. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 230. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 231. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 232. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 233. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 258. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 259. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 260. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 261. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 262. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 263. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 264. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 265. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 266. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 267. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. GCC ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GCC ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GCC ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. GCC ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. GCC ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. GCC ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 275. GCC ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 276. GCC ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 277. GCC ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 278. GCC ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 279. GCC ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 280. GCC ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 281. GCC ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 282. GCC ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 283. GCC ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. GCC ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 307. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 308. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 309. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 310. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 311. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 312. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 313. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 314. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 315. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. G7 ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 318. G7 ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 319. G7 ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. G7 ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. G7 ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 322. G7 ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 323. G7 ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 324. G7 ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 325. G7 ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 326. G7 ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 327. G7 ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 328. G7 ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 329. G7 ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 330. G7 ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 331. G7 ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 332. G7 ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 333. NATO ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 334. NATO ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 335. NATO ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 336. NATO ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 337. NATO ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 338. NATO ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 339. NATO ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 340. NATO ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 341. NATO ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 342. NATO ATHERECTOMY DEVICES MARKET SIZ